The efficacy of proton pump inhibitors for the treatment of asthma in adults

Archives of Internal Medicine

Volumn 171, Issue 7, 2011, Pages 620-629

  Chan, Walter W ^a   Chiou, Mph Eric ^b   Obstein, Keith L ^a   Tignor, April S ^a   Whitlock, Tom L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ASTHMA; BACKACHE; BRONCHITIS; DRUG EFFICACY; DRUG INDUCED HEADACHE; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMAN; META ANALYSIS; NAUSEA; PEAK EXPIRATORY FLOW; PNEUMONIA; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHINOPHARYNGITIS; TREATMENT OUTCOME;

ASTHMA; GASTROESOPHAGEAL REFLUX; HUMANS; PEAK EXPIRATORY FLOW RATE; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79955163301     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.116     Document Type: Review

References (69)

1. Fanta CH. Asthma. N Engl J Med. 2009;360(10): 1002-1014.
2. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma- Summary Report 2007. J Allergy Clin Immunol. 2007;120(5)(suppl):S94-S138.
3. Camilleri M, Dubois D, Coulie B, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005;3(6):543-552.
4. Sontag SJ, O'Connell S, Khandelwal S, et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology. 1990;99(3):613-620.
5. Allen CJ, Newhouse MT. Gastroesophageal reflux and chronic respiratory disease. Am Rev Respir Dis. 1984;129(4):645-647.
6. Ducoloné A, Vandevenne A, Jouin H, et al. Gastroesophageal reflux in patients with asthma and chronic bronchitis. Am Rev Respir Dis. 1987; 135(2):327-332.
7. Richter JE. Asthma and gastroesophageal reflux disease: the truth is difficult to define. Chest. 1999; 116(5):1150-1152.
8. Kiljander TO, Laitinen JO. The prevalence of gastroesophageal reflux disease in adult asthmatics. Chest. 2004;126(5):1490-1494.
9. Wu DN, Tanifuji Y, Kobayashi H, et al. Effects of esophageal acid perfusion on airway hyperresponsiveness in patients with bronchial asthma. Chest. 2000;118(6):1553-1556.
10. Harding SM, Schan CA, Guzzo MR, Alexander RW, Bradley LA, Richter JE. Gastroesophageal reflux- induced bronchoconstriction: is microaspiration a factor? Chest. 1995;108(5):1220-1227.
11. Zerbib F, Guisset O, Lamouliatte H, Quinton A, Galmiche JP, Tunon-De-Lara JM. Effects of bronchial obstruction on lower esophageal sphincter motility and gastroesophageal reflux in patients with asthma. Am J Respir Crit Care Med. 2002; 166(9):1206-1211.
12. Khan M, Santana J, Donnellan C, Preston C, Moayyedi P. Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev. 2007;(2):CD003244.
13. DeVault KR, Castell DO; American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100(1):190-200.
14. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al; American Gastroenterological Association. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008; 135(4):1383-1391, 1391.e1-5. doi:10.1053/j.gastro.2008.08.045.
15. Kiljander TO, Junghard O, Beckman O, Lind T. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med. 2010;181 (10):1042-1048.
16. Mastronarde JG, Anthonisen NR, Castro M, et al; American Lung Association Asthma Clinical Research Centers. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med. 2009;360(15):1487-1499.
17. Kiljander TO, Salomaa ER, Hietanen EK, Terho EO. Gastroesophageal reflux in asthmatics: a doubleblind, placebo-controlled crossover study with omeprazole. Chest. 1999;116(5):1257-1264.
18. Boeree MJ, Peters FT, Postma DS, Kleibeuker JH. No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a) symptomatic gastro-oesophageal reflux. Eur Respir J. 1998;11(5):1070-1074.
19. Ford GA, Oliver PS, Prior JS, Butland RJ, Wilkinson SP. Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-oesophageal reflux: a placebo-controlled cross-over study. Postgrad Med J. 1994;70(823):350-354.
20. Kiljander TO, Harding SM, Field SK, et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med. 2006;173(10):1091-1097.
21. Levin TR, Sperling RM, McQuaid KR. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux. Am J Gastroenterol. 1998;93(7):1060-1063.
22. Peterson KA, Samuelson WM, Ryujin DT, et al. The role of gastroesophageal reflux in exercisetriggered asthma: a randomized controlled trial. Dig Dis Sci. 2009;54(3):564-571.
23. dos Santos LH, Ribeiro IO, Sánchez PG, Hetzel JL, Felicetti JC, Cardoso PF. Evaluation of pantoprazol treatment response of patients with asthma and gastroesophageal reflux: a randomized prospective double-blind placebo-controlled study. J Bras Pneumol. 2007;33(2):119-127.
24. Gibson PG, Henry RL, Coughlan JL. Gastrooesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev. 2003; (2):CD001496.
25. Sopo SM, Radzik D, Calvani M. Does treatment with proton pump inhibitors for gastroesopha- geal reflux disease (GERD) improve asthma symptoms in children with asthma and GERD? a systematic review. J Investig Allergol Clin Immunol.2009;19(1):1-5.
26. Littner MR, Leung FW, Ballard ED II, Huang B, Samra NK; Lansoprazole Asthma Study Group. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest. 2005; 128(3):1128-1135.
27. Salas M, Ward A, Caro J. Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? a meta analysis of randomized clinical trials. BMC Gastroenterol. 2002;2:17.
28. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials. 1995; 16(1):62-73.
29. Reddel HK, Salome CM, Peat JK, Woolcock AJ. Which index of peak expiratory flow is most useful in the management of stable asthma? Am J Respir Crit Care Med. 1995;151(5):1320-1325.
30. Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest. 1999;115 (5):1265-1270.
31. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ.2003;327(7414):557-560.
32. Duval S, Tweedie R. Trim and fill: a simple funnelplot- based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56(2):455-463.
33. Stroup DF, Berlin JA, Morton SC, et al; Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. Meta-analysis of Observational Studies in Epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008-2012.
34. Teichtahl H, Kronborg IJ, Yeomans ND, Robinson P. Adult asthma and gastro-oesophageal reflux: the effects of omeprazole therapy on asthma. Aust N Z J Med. 1996;26(5):671-676.
35. Størdal K, Johannesdottir GB, Bentsen BS, et al. Acid suppression does not change respiratory symptoms in children with asthma and gastrooesophageal reflux disease. Arch Dis Child. 2005; 90(9):956-960.
36. Khorasani EN, Fallahi GH, Mansouri F, Rezaei N. The effect of omeprazole on asthmatic adolescents with gastroesophageal reflux disease. Allergy Asthma Proc. 2008;29(5):517-520.
37. Khoshoo V, Haydel R Jr. Effect of antireflux treatment on asthma exacerbations in nonatopic children. J Pediatr Gastroenterol Nutr. 2007; 44(3):331-335.
38. Ours TM, Kavuru MS, Schilz RJ, Richter JE. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol. 1999;94 (11):3131-3138.
39. Meier JH, McNally PR, Punja M, et al. Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? a doubleblind, placebo-controlled crossover study. Dig Dis Sci. 1994;39(10):2127-2133.
40. Bucknall C, Stanton A, Miller G, Rajoriya N, Babu S, Mackenzie J. The impact of normalization of esophageal acid profile by incremental protein pump inhibitors dosing in difficult asthma patients with proven gastro-esophageal acid reflux. J Asthma. 2009;46(5):506-511.
41. Shimizu Y, Dobashi K, Kobayashi S, et al. A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease. Tohoku J Exp Med.2006;209(3):181-189.
42. Calabrese C, Fabbri A, Areni A, Scialpi C, Zahlane D, Di Febo G. Asthma and gastroesophageal reflux disease: effect of long-term pantoprazole therapy. World J Gastroenterol. 2005;11(48): 7657-7660.
43. Jiang SP, Liang RY, Zeng ZY, Liu QL, Liang YK, Li JG. Effects of antireflux treatment on bronchial hyper-responsiveness and lung function in asthmatic patients with gastroesophageal reflux disease. World J Gastroenterol. 2003;9(5):1123-1125.
44. Kiljander T, Salomaa ER, Hietanen E, Helenius H, Liippo K, Terho EO. Asthma and gastrooesophageal reflux: can the response to antireflux therapy be predicted? Respir Med. 2001; 95(5):387-392.
45. Tsugeno H, Mizuno M, Fujiki S, et al. A protonpump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux. Scand J Gastroenterol.2003;38(5):456-461.
46. Harding SM, Richter JE, Guzzo MR, Schan CA, Alexander RW, Bradley LA. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med. 1996;100 (4):395-405.
47. Wong CH, Chua CJ, Liam CK, Goh KL. Gastrooesophageal reflux disease in "difficult-tocontrol" asthma: prevalence and response to treatment with acid suppressive therapy. Aliment Pharmacol Ther. 2006;23(9):1321-1327.
48. Sharma B, Sharma M, Daga MK, Sachdev GK, Bondi E. Effect of omeprazole and domperidone on adult asthmatics with gastroesophageal reflux. World J Gastroenterol. 2007;13(11):1706-1710.
49. Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying "well-controlled" and "not wellcontrolled" asthma using the Asthma Control Questionnaire. Respir Med. 2006;100:616-621.
50. American Thoracic Society. Definitions and classification of chronic bronchitis, asthma and pulmonary emphysema. Am Rev Respir Dis. 1962; 85:762-768.
51. Eurich DT, Sadowski CA, Simpson SH, Marrie TJ, Majumdar SR. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs. Am J Med. 2010;123(1):47-53.
52. Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ. 2008; 179(4):319-326.
53. Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. AmJ Gastroenterol. 2007; 102(9):2047-2057.
54. Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2010;8(6):504-508.
55. Santanello NC, Zhang J, Seidenberg B, Reiss TF, Barber BL. What are minimal important changes for asthma measures in a clinical trial? Eur Respir J. 1999;14(1):23-27.
56. Bateman ED, Britton M, Carrillo J, Almeida J, Wixon C. Salmeterol/fluticasone combination inhaler: a new, effective and well tolerated treatment for asthma. Clin Drug Investig. 1998;16(3):193-201.
57. Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers. Can Respir J.1999;6(1):45-51.
58. Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroiddependent asthma. Respir Med. 1999;93(12): 876-884.
59. Perng DW, Huang HY, Lee YC, Perng RP. Leukotriene modifier vs inhaled corticosteroid in mild-to-moderate asthma: clinical and antiinflammatory effects. Chest. 2004;125(5): 1693-1699.
60. Reddel HK, Taylor DR, Bateman ED, et al; American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/ European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59-99.
61. Mansfield LE, Stein MR. Gastroesophageal reflux and asthma: a possible reflex mechanism. Ann Allergy. 1978;41(4):224-226.
62. Field SK. Gastroesophageal reflux and asthma: can the paradox be explained? Can Respir J. 2000; 7(2):167-176.
63. Stovold R, Forrest IA, Corris PA, et al. Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection. Am J Respir Crit Care Med. 2007;175(12):1298-1303.
64. D'Ovidio F, Mura M, Tsang M, et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg. 2005;129(5):1144-1152.
65. Harding SM, Guzzo MR, Richter JE. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med. 2000;162(1):34-39.
66. Hogan WJ. Spectrum of supraesophageal complications of gastroesophageal reflux disease. Am J Med. 1997;103(5)(suppl 1):77S-83S.
67. Harding SM. Gastroesophageal reflux, asthma, and mechanisms of interaction. Am J Med. 2001; 111(8)(suppl 1):8S-12S.
68. Field SK, Underwood M, Brant R, Cowie RL. Prevalence of gastroesophageal reflux symptoms in asthma. Chest. 1996;109(2):316-322.
69. Simpson WG. Gastroesophageal reflux disease and asthma: diagnosis and management. Arch Intern Med. 1995;155(8):798-803.